Expert opinions: Will MFN reduce US drug prices?Robots in maternity care.What drives company decisions on new medicine launches and UK investment?Incorporating dynamic pricing into HEOR models (dynamicpv)Tale of 2 value sets.How to handle the lows? Honesty.Integrity in journalism: Giannis edition.
July 2, 2026
- With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
- Debunked Episode 28: A Little More Transparency, A Little More Action
- Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It
- Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data
Headlines
